Published: 2018-11-12 10:10 | Updated: 2018-11-12 14:46

Interviews with Richard Rosenquist about the ERIC-initiative on CLL

ERIC, the European Research Initiative on CLL, is a European organisation devoted to improving the outcome of patients with chronic lymphocytic leukemia (CLL) and related diseases. ERIC is open to all physicians and scientists working/interested in the field of chronic lymphocytic leukemia and related disorders.

The Video Journal of Hematological Oncology made three interviews with Professor Richard Rosenquist Brandell at the ERIC Meeting 2018 in Barcelona. Listen to Richard when he talks about large-scale collaborations across multiple centres to characterize relevant mutations in chronic lymphocytic leukemia (CLL) and he also talks about future steps, such as identifying the frequency, co-occurrence and prognostic value of genetic aberrations.

Current ERIC research in the CLL genomics field

Genomic discoveries in CLL

Resistance mechanisms in CLL